{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:26:01Z","timestamp":1762608361742,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12029-021-00675-1","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:02:37Z","timestamp":1627084957000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic Factors for Survival in Transverse Colon Cancers"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-2360","authenticated-orcid":false,"given":"Ahmet","family":"K\u00fc\u00e7\u00fckarda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"G\u00f6kyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezin","family":"Say\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130vo","family":"G\u00f6kmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"K\u00f6stek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet Bekir","family":"Hac\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sernaz","family":"Uzuno\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rfan","family":"\u00c7i\u00e7in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"issue":"3","key":"675_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","volume":"23","author":"T Nawa","year":"2008","unstructured":"Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23(3):418\u201323.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"675_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14740\/gr1062w","volume":"11","author":"B Baran","year":"2018","unstructured":"Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterology Res. 2018;11(4):264\u201373.","journal-title":"Gastroenterology Res"},{"key":"675_CR3","unstructured":"https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/10_8_9-Colorectum-fact-sheet.pdf (Accessed on 20 Apr\u00a02021)."},{"issue":"2","key":"675_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejso.2010.12.004","volume":"37","author":"F Benedix","year":"2011","unstructured":"Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, Kube R. Colon carcinoma\u2014classification into right and left sided cancer or according to colonic sub-site?\u2013Analysis of 29,568 patients. Eur J Surg Oncol. 2011;37(2):134\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 4S","key":"675_CR5","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1200\/JCO.2016.34.15_suppl.3504","volume":"34","author":"AP Venook","year":"2016","unstructured":"Venook AP, Niedzwiecki D, Innocenti F, et al. Impact of primary tumor location on overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC): analysis of CALGB\/SWOG 80405 (Alliance). J Clin Oncol. 2016;34(Suppl 4S):3504.","journal-title":"J Clin Oncol"},{"issue":"5","key":"675_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1245\/s10434-019-07164-7","volume":"26","author":"GW Ha","year":"2019","unstructured":"Ha GW, Kim JH, Lee MR. Oncologic effects of primary tumor-sidedness on patients with stages 1\u20133 colon cancer: a meta-analysis. Ann Surg Oncol. 2019;26(5):1366\u201375.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"675_CR7","first-page":"11","volume":"23","author":"K Kim","year":"2018","unstructured":"Kim K, Kim YW, Shim H, Kim BR, Kwon HY. Differences in clinical features and oncologic outcomes between metastatic right and left colon cancer. J Buon. 2018;23(7):11\u20138.","journal-title":"J Buon"},{"issue":"5","key":"675_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/1078-0432.CCR-17-2484","volume":"24","author":"JM Loree","year":"2018","unstructured":"Loree JM, Pereira AAL, Lam M, et al. Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes. Clin Cancer Res. 2018;24(5):1062\u201372.","journal-title":"Clin Cancer Res"},{"key":"675_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/j.1463-1318.2012.03048.x","volume":"14","author":"AG Powell","year":"2012","unstructured":"Powell AG, Wallace R, McKee RF, et al. The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer. Colorectal Dis. 2012;14:1493\u20139.","journal-title":"Colorectal Dis"},{"key":"675_CR10","doi-asserted-by":"crossref","unstructured":"Cremolini C, Benelli M, Fontana E, et al. Benefit from anti-EGFRs in\u00a0RAS\u00a0and\u00a0BRAF\u00a0wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study. ESMO Open. 2019;4(2):e000489.","DOI":"10.1136\/esmoopen-2019-000489"},{"issue":"9","key":"675_CR11","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.3390\/cancers12092457","volume":"12","author":"M Roberto","year":"2020","unstructured":"Roberto M, Arrivi G, Lo Bianco F, et al. Evaluation of prognostic factors for survival in transverse colon cancer. Cancers (Basel). 2020;12(9):2457.","journal-title":"Cancers (Basel)"},{"issue":"49","key":"675_CR12","doi-asserted-by":"publisher","first-page":"86356","DOI":"10.18632\/oncotarget.21169","volume":"8","author":"ME Salem","year":"2017","unstructured":"Salem ME, Weinberg BA, Xiu J, et al. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget. 2017;8(49):86356\u201368.","journal-title":"Oncotarget"},{"key":"675_CR13","doi-asserted-by":"crossref","unstructured":"Lim DR, Kuk JK, Kim T, Shin EJ. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: which side is better outcome? Medicine (Baltimore). 2017;96(42):e8241.","DOI":"10.1097\/MD.0000000000008241"},{"issue":"2","key":"675_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/00015458.2013.11680895","volume":"113","author":"I van Rongen","year":"2013","unstructured":"van Rongen I, Damhuis RA, van der Hoeven JA, Plaisier PW. Comparison of extended hemicolectomy versus transverse colectomy in patients with cancer of the transverse colon. Acta Chir Belg. 2013;113(2):107\u201311.","journal-title":"Acta Chir Belg"},{"key":"675_CR15","first-page":"23","volume":"8","author":"D Coco","year":"2020","unstructured":"Coco D, Leanza S. Cancer of the transverse colon: comparison of extended right or left hemicolectomy versus transverse colectomy. Open Access Maced J Med Sci. 2020;8:23\u20136.","journal-title":"Open Access Maced J Med Sci"},{"issue":"3","key":"675_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/codi.15403","volume":"23","author":"S Morarasu","year":"2021","unstructured":"Morarasu S, Clancy C, Cronin CT, Matsuda T, Heneghan HM, Winter DC. Segmental versus extended colectomy for tumours of the transverse colon: a systematic review and meta-analysis. Colorectal Dis. 2021;23(3):625\u201334.","journal-title":"Colorectal Dis"},{"issue":"5","key":"675_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00268-010-0443-2","volume":"34","author":"YH Ho","year":"2010","unstructured":"Ho YH, Siu SK, Buttner P, Stevenson A, Lumley J, Stitz R. The effect of obstruction and perforation on colorectal cancer disease-free survival. World J Surg. 2010;34(5):1091\u2013101.","journal-title":"World J Surg"},{"key":"675_CR18","doi-asserted-by":"crossref","unstructured":"Ghazi S, Berg E, Lindblom A, Lindforss U. Low-Risk Colorectal Cancer Study Group. Clinicopathological analysis of colorectal cancer: a comparison between emergency and elective surgical cases. World J Surg Oncol. 2013;11:133.","DOI":"10.1186\/1477-7819-11-133"},{"issue":"19","key":"675_CR19","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27(19):3109\u201316.","journal-title":"J Clin Oncol"},{"issue":"25","key":"675_CR20","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","volume":"29","author":"ES O'Connor","year":"2011","unstructured":"O\u2019Connor ES, Greenblatt DY, LoConte NK, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011;29(25):3381\u20138.","journal-title":"J Clin Oncol"},{"key":"675_CR21","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. https:\/\/www.nccn.org\/professionals\/physician_gls (Accessed on 20 Apr\u00a02021)."},{"issue":"10","key":"675_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305.","journal-title":"Ann Oncol"},{"key":"675_CR23","unstructured":"AJCC Cancer Staging Manual, 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.143."},{"issue":"10","key":"675_CR24","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","volume":"25","author":"E Missiaglia","year":"2014","unstructured":"Missiaglia E, Jacobs B, D\u2019Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25(10):1995\u20132001.","journal-title":"Ann Oncol"},{"issue":"1","key":"675_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0039-6060(98)70223-5","volume":"123","author":"S Forster","year":"1998","unstructured":"Forster S, Sattler HP, Hack M, et al. Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features. Surgery. 1998;123(1):13\u20138.","journal-title":"Surgery"},{"issue":"3","key":"675_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247\u201357.","journal-title":"N Engl J Med"},{"issue":"9","key":"675_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/90.9.675","volume":"90","author":"HJ Andreyev","year":"1998","unstructured":"Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Kirsten ras mutations in patients with colorectal cancer: the multicenter \u201cRASCAL\u201d study. J Natl Cancer Inst. 1998;90(9):675\u201384.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"675_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00384-020-03589-9","volume":"35","author":"M Roberto","year":"2020","unstructured":"Roberto M, Marchetti P, Arrivi G, et al. The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference. Int J Colorectal Dis. 2020;35(8):1513\u201327.","journal-title":"Int J Colorectal Dis"},{"issue":"9","key":"675_CR29","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","volume":"27","author":"DP Modest","year":"2016","unstructured":"Modest DP, Ricard I, Heinemann V, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27(9):1746\u201353.","journal-title":"Ann Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-021-00675-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T09:15:43Z","timestamp":1648026943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-021-00675-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1007\/s12029-021-00675-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"15 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained. All procedures performed in studies involving participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and is later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}